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STUDY QUESTION: Is high adiposity in childhood associated with menstrual irregularity 22 
and polycystic ovary syndrome (PCOS) in later life?  23 
SUMMARY ANSWER: Overall, greater childhood BMI was associated with menstrual 24 
irregularity, and greater childhood BMI and waist/height ratio (WHtR) in white but not black 25 
participants were associated with PCOS in adulthood.  26 
WHAT IS KNOWN ALREADY: Increased childhood BMI has been associated with 27 
irregular menstrual cycles and PCOS symptoms in adulthood in two longitudinal population-28 
based studies, but no study has reported on associations with childhood abdominal obesity. 29 
Few studies have investigated whether there are racial differences in the associations of 30 
adiposity with PCOS though there has been some suggestion that associations with high BMI 31 
may be stronger in white girls than in black girls.  32 
STUDY DESIGN, SIZE, DURATION: The study included 1,516 participants (aged 26-41 33 
years) from the Australian Childhood Determinants of Adult Health study (CDAH) and 1,247 34 
participants (aged 26-57 years) from the biracial USA Babies sub-study of the Bogalusa 35 
Heart Study (BBS) who were aged 7-15 years at baseline. At follow-up, questions were asked 36 
about menstruation (current for CDAH or before age 40 years for BBS), ever having had a 37 
diagnosis of PCOS and symptoms of PCOS.  38 
PARTICIPANTS/MATERIALS, SETTING, METHODS: In CDAH, a single childhood 39 
visit was conducted in 1985. In BBS, multiple childhood visits occurred from 1973 to 2000 40 
and race was reported (59% white; 41% black). In childhood, overweight and obesity were 41 
defined by international age-sex-specific standards for BMI and WHtR was considered as an 42 





relative risks (RRs) adjusting for childhood age, highest parental and own education, and age 44 
at menarche. 45 
MAIN RESULTS AND THE ROLE OF CHANCE: The prevalence of childhood obesity 46 
was 1.1% in CDAH and 7.5% in BBS. At follow-up, menstrual irregularity was reported by 47 
16.7% of CDAH and 24.5% of BBS participants. The prevalence of PCOS was 7.4% in 48 
CDAH and 8.0% in BBS participants. In CDAH, childhood obesity was associated with 49 
menstrual irregularity (RR=2.84, 95% CI:1.63-4.96) and PCOS (RR=4.05, 95% CI:1.10-50 
14.83) in adulthood. With each 0.01 unit increase in childhood WHtR there was a 6% (95% 51 
CI: 1%-11%) greater likelihood of PCOS. Overall, in BBS, childhood obesity was associated 52 
with increased risk of menstrual irregularity (RR=1.44, 95% CI: 1.08-1.92) in adulthood. 53 
Significant interaction effects between race and childhood adiposity were detected in 54 
associations with PCOS. In BBS white participants, childhood obesity was associated with 55 
PCOS (RR=2.93, 95% CI: 1.65-5.22) and a 0.01 unit increase in childhood WHtR was 56 
associated with an 11% (95% CI: 5%-17%) greater likelihood of PCOS in adulthood. In BBS 57 
black participants, no statistically significant associations of childhood adiposity measures 58 
with PCOS were observed. 59 
LIMITATIONS, REASONS FOR CAUTION: The classification of menstrual irregularity 60 
and PCOS was based on self-report by questionnaire, which may have led to misclassification 61 
of these outcomes. However, despite the limitations of the study, the prevalence of menstrual 62 
irregularity and PCOS in the two cohorts was consistent with the literature. While the study 63 
samples at baseline were population-based, loss to follow-up means the generalizability of 64 
the findings is uncertain. 65 
WIDER IMPLICATIONS OF THE FINDINGS: Greater childhood adiposity indicates a 66 





early indicator of underlying hormonal or metabolic disorders needs clarification. The 68 
stronger associations of adiposity with PCOS in white than black participants suggest that 69 
there are racial differences in childhood adiposity predisposing to the development of PCOS 70 
and other environmental or genetic factors are also important. 71 
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544923 and 1128373). The Bogalusa Heart Study is supported by US National Institutes of 74 
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Introduction  88 
Menstrual irregularity and polycystic ovary syndrome (PCOS) have been associated with 89 
higher risk of lower fecundity and cardiovascular diseases (Solomon, et al., 2002; West, et 90 
al., 2014) as well as some cancers (Harris, et al., 2018; Harris, et al., 2017). PCOS is 91 
recognized as the most common heterogeneous endocrine disorder, affecting 8-13% of 92 
women of reproductive age (March, et al., 2010). Irregular menstrual cycles are part of the 93 
three diagnostic criteria (National Institutes of Health, Rotterdam and Androgen Excess 94 
Society diagnostic criteria) for PCOS in addition to hyperandrogenism and polycystic ovarian 95 
morphology (Teede, et al., 2018).  96 
General and abdominal obesity are associated with a greater risk of menstrual irregularity in 97 
adult women (Douchi, et al., 2002; Hahn, et al., 2013; Jacobsen, et al., 2012; Wei, et al., 98 
2009). Our previous cross-sectional study suggested that obese women, defined by either 99 
BMI or waist circumference, were twice as likely to have irregular menstruation, compared 100 
with normal weight women (Wei, et al., 2009). However, the association between adult 101 
obesity and PCOS is inconclusive. Although obesity, particularly abdominal obesity, is a 102 
common trait in women with PCOS, it is not part of the diagnostic criteria. The prevalence of 103 
obesity varies among different populations and races but the prevalence of PCOS is relatively 104 
uniform (Legro, 2012). This implies that obesity might not cause PCOS or there could be 105 
geographic/ethnic differences affecting the relationship between obesity and PCOS. 106 
Only two previous population-based longitudinal studies (Laitinen, et al., 2003; Lake, et al., 107 
1997) have investigated the associations between childhood obesity, adult menstrual 108 
irregularity and PCOS, in which childhood BMI was the only indicator of obesity. The 1958 109 
British birth cohort study of 5,770 girls reported that overweight and obesity at 7 years of age 110 





Northern Finland 1966 birth cohort of 2,007 girls suggested that overweight and obesity at 112 
age 14 years were associated with self-reported PCOS at age 31 years(Laitinen, et al., 2003). 113 
Two further papers based on the same Northern Finland cohort reported associations of 114 
weight gain (Ollila, et al., 2016) and age at adiposity rebound with PCOS (Koivuaho, et al., 115 
2019). Another study based on clinical study samples suggested that change in z-score from 116 
weight at birth to weight in adolescence may be greater in girls with PCOS than in healthy 117 
controls (de Zegher, et al., 2017). 118 
In this study we used two cohorts with different racial characteristics who were followed 119 
through childhood to adulthood. We aimed first to investigate the associations of obesity 120 
(including abdominal obesity) in childhood with menstrual irregularity and PCOS in 121 
adulthood and, second to determine whether these associations differed by country (Australia 122 
and USA) and race (white and black).  123 
 124 
Materials and Methods 125 
The Childhood Determinants of Adult Health Study: a cohort from Australia 126 
Participants 127 
The Childhood Determinants of Adult Health Study (CDAH) study is a follow-up of 128 
participants in the 1985 Australian Schools Health and Fitness Survey (ASHFS), a nationally 129 
representative sample of 8,498 school children (4,191 girls) aged 7-15 years (Gall, et al., 130 
2009) (Fig. 1). During 2004-06, the first follow-up (CDAH-1) was conducted when 131 
participants were 26-36 years and 1,598 female participants responded to questions on their 132 
menstrual cycle characteristics and PCOS. Among them 652 participants attended a study 133 
clinic and had plasma hormone measurements including total testosterone concentrations and 134 





was conducted during 2009-11 when participants were aged 31-41 years and 1,123 136 
participants completed the same questions about menstrual cycles and PCOS. The current 137 
study included 1,516 women who completed questions on menstrual cycles and/or PCOS in 138 
CDAH-1 and/or CDAH-2. 139 
The study was approved by the Southern Tasmania Health and Medical Human Research 140 
Ethics Committee. Written informed consent was obtained during childhood from parents and 141 
at each follow-up from participants. 142 
Childhood anthropometric measurements 143 
BMI, calculated as weight (kg)/height (m)2, was derived from measured weight and height. 144 
BMI was classified as normal, overweight or obese according to the international age-sex-145 
specific cut-points (Cole, et al., 2000). BMI-z score was calculated based on age-sex-specific 146 
World Health Organization Child Growth standards (2006). Waist circumference was taken 147 
at the level of the umbilicus to the nearest 0.1 cm. Waist/height ratio (WHtR), calculated as 148 
waist circumference divided by height (cm), was the indicator of abdominal obesity when 149 
WHtR≥0.5 (Brambilla, et al., 2013). 150 
Adult anthropometric measurements 151 
Participants who attended CDAH-1 clinics (n=2,329) had weight, height, and waist 152 
circumference measured. Participants who did not visit clinics (n=1,556) self-reported their 153 
weight and height, and a correction factor was applied to adjust for error, as described 154 
previously (Venn, et al., 2007). BMI (kg/m2) was calculated from height and weight. Weight 155 
and height were self-reported at CDAH-2 and adjusted for error as described above. Adult 156 
BMI was categorized as normal (BMI<25 kg/m2), overweight (25.0≤BMI≤29.9 kg/m2) or 157 





Adult menstrual irregularity and PCOS  159 
We defined menstrual cycle length as the time from the first day of one period to the first day 160 
of the next and participants were questioned on the length of their usual menstrual cycle. 161 
Menstrual irregularity was defined as menstrual cycles ≥35 days or <25 days or reported as 162 
extremely irregular in CDAH-1 and/or CDAH-2. Women who were currently pregnant 163 
(n=31), using hormonal contraceptives (n=411) or had a hysterectomy (n=1) were excluded. 164 
Women were defined as having PCOS if they self-reported in CDAH-1 and/or CDAH-2 that   165 
they had ever been told by a doctor or they reported two symptoms of PCOS. The symptoms 166 
were menstrual cycle ≥35 days or totally variable, and hirsutism. The validity of identifying 167 
women with PCOS by way of similar questions has been reported previously as moderately 168 
high (Taponen, et al., 2004). The presence of hirsutism was defined as ever having seen a 169 
doctor because of concern about the amount of hair on their face. 170 
Covariates 171 
Age at menarche was self-reported in adulthood. Smoking history in childhood and adulthood 172 
were coded as ever or never smoked. Ever smoked in childhood was defined as having ≥10 173 
cigarettes in their life. Former and current smokers in adulthood were defined as ever 174 
smoked. Highest parental education and own-education were classified as high school only, 175 
vocational training and any university education. Childhood alcohol consumption was 176 
classified as none (never consume alcohol), light (consume alcohol less than once/week), 177 
moderate (consume alcohol 1-2 days/week), heavy (consume alcohol 3-4 days/week) and 178 
very heavy (consume alcohol ≥ 5 days/week). Alcohol consumption in adulthood was 179 
classified according to daily alcohol intake: none (0 alcoholic drinks/day), light (0-1 alcoholic 180 





heavy intake (>3 alcoholic drinks/day) based on Australian guidelines (Australian 182 
Government, 2009). 183 
The Bogalusa Heart Study: a cohort from the USA 184 
Participants 185 
The Bogalusa Heart Study (BHS) is a biracial (65% white and 35% black) prospective cohort 186 
study of cardiovascular risk factors among children and young adults from Bogalusa, LA, 187 
USA (Brook, 1981). Initial study participants aged 3-18 years were enrolled from schools in 188 
1973 and additional participants were recruited over time. Data collection occurred 189 
approximately every 2 years for children and 5 years for adults. These cross-sectional studies 190 
of children or adults were combined to create the overall BHS population.  191 
The Bogalusa Babies sub-study (BBS) began in May 2013 to examine the role of 192 
cardiovascular risk factors in childhood on reproductive outcomes. Women with at least one 193 
BHS visit (n=5,914) were eligible to participate. We included 1,247 female participants who 194 
were aged 7-15 years during childhood visits (to align with the CDAH study), who 195 
participated in BBS when they were aged 26-57 years, and had height and weight reported 196 
between ages 26 and 40 years to align with their report of their menstrual cycle 197 
characteristics prior to age 40 years (Fig. 2).  198 
For child participants, parental permission and consent of the child were obtained and written 199 
informed consent was obtained from adult participants. All study procedures were approved 200 







Childhood anthropometric measurements 204 
All BHS surveys followed an identical protocol for anthropometric measurements. In the 205 
subsample of BBS used in the current study, a total of 298 participants had childhood waist 206 
and hip circumference measured. Height, weight and waist circumference were measured 207 
twice to within 0.1cm or 0.1kg and mean values obtained. BMI, BMI z-score, WHtR, obesity 208 
and abdominal obesity were calculated or classified using the same criteria as described in the 209 
CDAH study.  210 
Adult anthropometric measurements 211 
Adult height and weight were recorded in the BBS (Paley, et al., 2004). Where necessary, 212 
height and weight before age 40 years were extracted from records of the BHS (Berkey, et 213 
al., 1993). BMI, overweight and obesity were calculated or classified using the same criteria 214 
as described in the CDAH study. 215 
Adult menstrual irregularity and PCOS  216 
Data on menstrual cycle characteristics were collected by questioning participants on the 217 
length of the average menstrual cycle between age 16 and 40 years (excluding any time spent 218 
pregnant, receiving birth control pills or injections, after menopause, or after having both 219 
ovaries or the uterus surgically removed). Participants reporting an average menstrual cycle 220 
of ≥35 days, <25 days, or totally variable were considered to have menstrual irregularity.  221 
The classification of PCOS was based on the presence of both menstrual cycle ≥35 days or 222 
totally variable and hirsutism, or self-reported ever having been told by a doctor that she had 223 
PCOS. Hirsutism was determined by a series questions asking about the tendency to grow 224 





breasts, back, belly, upper arms and upper thighs. Those who indicated three or more sites 226 
were considered as having clinical hirsutism. 227 
Covariates 228 
Race (white/black) was recorded at the initial BHS visit. As previously described (Wattigney, 229 
et al., 1999), information on age at menarche was obtained by a registered nurse. Smoking 230 
history in childhood and adulthood were coded as ever (currently or formerly at any visit) and 231 
never smoked. Highest parental and own-education were classified as high school only, 232 
vocational training, and college or more (any university). Childhood and adulthood alcohol 233 
consumption were classified as none (tried or never drink), light (drink less than once/week), 234 
moderate (drink once or twice/week), heavy (drink 3-4 times/week) and very heavy drinker 235 
(drink daily or almost every day). 236 
Statistical analyses 237 
Means with SDs and numbers with proportions were used to describe participants’ 238 
sociodemographic characteristics, menstrual irregularity and PCOS in each cohort from 239 
baseline to follow-up. Taking into account the multiple adult visits conducted in CDAH and 240 
multiple childhood visits in BBS, multi-level generalized linear mixed effects models with 241 
Poisson regression were employed to estimate the relative risks (RRs) and 95% CIs. 242 
In BBS, approximately 50% of participants had missing data on age at menarche and more 243 
than 20% of participants had missing data on highest parental education. Multiple imputation 244 
by chained equations was used to impute the missing data (Azur, et al., 2011).  245 
Covariates remaining in the final models were variables which were causally related to the 246 





the coefficient of the principal study factor when added to the model. In analyses of the BBS, 248 
the models were additionally adjusted for race as appropriate.  249 
Interactions between race and childhood adiposity on menstrual irregularity and PCOS in 250 
BBS were investigated in the regression model. There was no interaction between race and 251 
obesity on menstrual irregularity (P=0.362), however, a statistically significant race 252 
interaction was present for PCOS (P=0.042). Therefore, PCOS analyses in BBS were further 253 
stratified by race. 254 
The following sensitivity analyses were conducted. First, we repeated the analysis by using 255 
the United States Centres for Disease Control and Prevention (CDC) growth reference to 256 
calculate BMI z-score and to classify childhood weight status (Harris, et al., 2018). Second, 257 
the analysis was repeated after excluding persons who may have been of black (n=8) or other 258 
non-white race (n=35) in CDAH (race was inferred from the childhood questionnaire 259 
including the information on father’s and mother’s country of birth and language spoken at 260 
home) to compare with the results in BBS white participants. Third, associations were 261 
examined with the change between birthweight z-score and BMI z-score in childhood in a 262 
subsample of BBS (n=788) with the relevant information on birthweight and gestational age 263 
available from birth certificates (Chen, et al., 2012). Fourth, as hyperandrogenism is also a 264 
key diagnostic feature for PCOS, the association of childhood adiposity with biochemical 265 
hyperandrogenism was analysed in a subsample of CDAH (n=652) who attended CDAH-1 266 
clinics and were not using hormonal contraceptives. Biochemical hyperandrogenism was 267 
assessed by calculated free testosterone levels (cFT) (Vermeulen, et al., 1999). The 268 
association of childhood adiposity with hirsutism was also analysed in CDAH and BBS. 269 
Fifth, we restricted our sample in BBS to women who were aged under 40 years at follow-up 270 
to ensure reporting of current menstrual characteristics and excluding retrospective reports 271 





investigate the associations of underweight in childhood with menstrual irregularity and 273 
PCOS in adulthood.  274 
All analyses were performed using STATA software, version 15.0 (Stata Corp., College 275 
Station, TX, USA); a p-value of <0.05 was considered statistically significant. 276 
Results 277 
Participant characteristics 278 
Our sample included 1,516 participants from the CDAH study and 1,247 (white: 730; black: 279 
517) participants from the BBS. Anthropometric and sociodemographic characteristics of 280 
participants in the two cohorts are shown in Table I. On average, BBS participants had a 281 
higher childhood BMI z-score and WHtR than CDAH participants. The prevalence of 282 
childhood obesity and abdominal obesity was 1.1% and 5.3% in CDAH and 7.5% (white: 283 
5.2%; black: 10.8%) and 22.5% (white: 20.2%; black: 23.8%) in BBS. At follow-up, the 284 
mean age in CDAH-1 was 31.5 years, and 36.4 years at CDAH-2. In BBS, the mean age was 285 
44.1 years. The prevalence of menstrual irregularity was 16.7% in CDAH and 24.5% in BBS 286 
(white: 25.4%; black: 23.2%). The prevalence of PCOS was 7.4% in CDAH (the average of 287 
CDAH-1 and CDAH-2) and 8.0% (white: 10.7%; black: 4.3%) in BBS. Identification of 288 
PCOS by menstrual characteristics and hirsutism alone classified seven more participants 289 
with PCOS in CDAH and 16 more participants in BBS.  290 
Childhood adiposity and menstrual irregularity  291 
Table II shows the associations of childhood adiposity with menstrual irregularity in CDAH 292 
and in the overall BBS. In CDAH (after adjusting for childhood age, age at menarche, highest 293 
parental and their own education), compared with normal weight girls, the risk of reporting 294 





in the BBS, when further adjusted for race, childhood obesity was associated with nearly 296 
twice the risk of having menstrual irregularity.  297 
Childhood adiposity and self-reported PCOS 298 
In CDAH, childhood obesity defined by BMI and childhood abdominal obesity defined by 299 
WHtR were significantly associated with an increased risk of self-reported PCOS (Table III). 300 
A 0.01 unit increase in childhood WHtR was associated with a 5% increased likelihood of 301 
self-reported PCOS. In the BBS sample overall, results were consistent with CDAH: 302 
childhood obesity was associated with a higher risk of self-reported PCOS and every 0.01 303 
unit increase in WHtR was associated with 8% greater likelihood of PCOS (Table III).  304 
Racial differences in the associations of self-reported PCOS in BBS 305 
Significant racial differences were observed in the associations of childhood adiposity with 306 
self-reported PCOS, but not with menstrual irregularity, in BBS white and black participants 307 
(Table IV). Childhood obesity and a 0.01 unit increase in WHtR were both associated with an 308 
increased risk of PCOS in BBS white participants, but no significant associations of 309 
childhood obesity or WHtR with PCOS were found in BBS black participants.  310 
Influence of weight status from childhood into adulthood  311 
The relative risk of menstrual irregularity by change of weight status from childhood to 312 
adulthood is displayed in Table V. Compared with participants who had persistently normal 313 
BMI in childhood and adulthood, those who became overweight or obese in adulthood 314 
reported a higher risk of menstrual irregularity in BBS. Participants who were persistently 315 
overweight/obese since childhood had significantly higher risks of menstrual irregularity in 316 





No significant association of any weight status category from childhood to adulthood with 318 
PCOS was found in BBS black participants (Table VI). In white participants, those who were 319 
overweight or obese in childhood only, or persistently overweight or obese from childhood to 320 
adulthood, had a significantly increased risk of PCOS (Table VI).   321 
Sensitivity analyses 322 
Similar estimates were found in sensitivity analyses in which the United States CDC 323 
standards were used to calculate childhood BMI z-score and classify childhood obesity 324 
according to BMI (Supplementary Table SI, Table SII and Table SIII). When women of non-325 
white races (n=43) were excluded in CDAH, the associations between increased childhood 326 
BMI and menstrual irregularity remained statistically significant. The associations between 327 
increased childhood BMI, WHtR and PCOS also remained statistically significant with only 328 
small changes in the mean coefficients (-2.5%-11.20%). In a subsample of participants who 329 
had birthweight and gestational age in BBS (n=788), we found the z-score increment between 330 
weight at birth and BMI in childhood was associated with increased risk of menstrual 331 
irregularity and PCOS in white participants but no statistically significant association was 332 
found in black participants (Supplementary Table SIV).  333 
In a subsample of participants who attended CDAH-1 clinics (n=652), childhood BMI z-334 
score (β= 2.82 pmol/l, 95% CI: 1.67-3.98) and childhood WHtR (β= 0.59 pmol/l, 95% CI: 335 
0.33-0.86) were positively associated with cFT in adulthood. In CDAH, childhood BMI z-336 
score (RR=1.50, 95% CI: 1.30-2.00) and WHtR (RR=1.07, 95% CI: 1.01-1.12) were 337 
positively associated with hirsutism at follow-up; similar associations of childhood BMI z-338 
score (RR=1.61 95% CI: 1.25-2.09) and WHtR (RR=1.13, 95% CI: 1.05-1.21) with hirsutism 339 





When restricting the sample to women who were aged under 40 years in the analysis of 341 
menstrual irregularity in BBS (n=431) (Supplementary Table SV), the risks of menstrual 342 
irregularity remained elevated for participants with high childhood adiposity, although less 343 
so, and achieved borderline significance for childhood obesity (RR=1.50, 95% CI 0.94-2.41, 344 
P=0.090) and childhood abdominal obesity (RR=1.55, 95% CI 0.99-2.41, P=0.055). No 345 
significant associations of childhood underweight in CDAH (n=14) and BBS (n=22) with 346 
menstrual irregularity and PCOS in adulthood were found.  347 
Discussion  348 
This study is the first to report the association of childhood abdominal obesity with menstrual 349 
irregularity and PCOS in adulthood, using data from two independent large prospective 350 
cohorts in two countries. Overall, in both cohorts, childhood obesity but not abdominal 351 
obesity was associated with greater risks of menstrual irregularity. A significant racial 352 
difference was observed in the associations of childhood obesity and abdominal obesity with 353 
PCOS, with significant associations found in white participants, but not in black participants. 354 
The risks of menstrual irregularity and PCOS were consistently significantly higher in 355 
participants with persistent overweight/obesity since childhood.  356 
The positive association between childhood obesity and adulthood menstrual irregularity is 357 
consistent with prior findings from the 1958 British birth cohort (Lake, et al., 1997). Though 358 
some studies have suggested that the distribution of body fat in adult women may be a risk 359 
factor of menstrual irregularity cross-sectionally (Douchi, et al., 2002; Wei, et al., 2009), no 360 
statistically significant association of childhood abdominal obesity with menstrual 361 
irregularity was found in CDAH and BBS. The mechanisms underlying the associations of 362 
greater childhood BMI with menstrual irregularity in adulthood may include a series of 363 





testosterone, LH, insulin, and reduced concentrations of SHBG in adulthood (Elizondo-365 
Montemayor, et al., 2017; Marcovecchio and Chiarelli, 2013). These changes may cause a 366 
disruption of normal ovulation and menstrual irregularity. 367 
It is known that PCOS and menstrual irregularity are strongly correlated. We found that the 368 
positive associations of childhood BMI and WHtR with self-reported PCOS in adulthood 369 
were strong in CDAH and BBS white participants. Menstrual irregularity is part of the 370 
diagnostic criteria for PCOS (Teede, et al., 2018), and childhood obesity was correlated with 371 
menstrual irregularity in the current study, therefore, this may explain the observed 372 
associations. Phenotypic features (including menstrual irregularity and hyperandrogenism) of 373 
PCOS are known to be regulated by obesity cross-sectionally, typically involving a 374 
distribution of central fat (de Zegher, et al., 2018; Legro, 2012). Our finding of the positive 375 
associations between childhood BMI, childhood WHtR and cFT in adulthood in a subsample 376 
of participants in CDAH suggested that higher childhood adiposity increased the risk of 377 
hyperandrogenism. Childhood obesity as well as abdominal obesity may act to promote 378 
menstrual irregularity and hyperandrogenism in those at higher risk of PCOS. 379 
No significant association of adiposity with PCOS was found in BBS black girls. A previous 380 
cross-sectional study by Christensen, et al. (2013) also reported that the association between 381 
BMI and PCOS was weaker in black girls than white girls. The literature has indicated that 382 
although there are substantial racial differences in the prevalence of obesity, the prevalence of 383 
PCOS is similar in different races (Azziz, et al., 2004; Knochenhauer, et al., 1998; Wolf, et 384 
al., 2018). In our study, BBS black participants had a higher prevalence of childhood obesity 385 
than white participants (10.8% versus 5.2%, respectively), but their prevalence of PCOS was 386 
lower than white participants (4.3% versus 10.7%, respectively). The explanations for this 387 
racial difference are unclear. It is possible that lower socioeconomic status and poorer health 388 





(Merkin, et al., 2016). These factors may thereby dilute the associations observed in black 390 
participants. However, in BBS, a stronger association of childhood adiposity with hirsutism 391 
was still observed among white compared to black participants. While previous studies have 392 
suggested that black women with PCOS have increased risk of metabolic syndrome and 393 
cardiovascular disease compared with white women with PCOS (Chan, et al., 2017; Hillman, 394 
et al., 2014), the associations of adiposity with PCOS between races have not been clearly 395 
defined. We are the first to report in longitudinal studies that there are racial differences in 396 
how childhood adiposity associates with the development of PCOS.  397 
The lack of association of childhood adiposity with PCOS in black participants also suggests 398 
that high childhood adiposity is not the only driver of adult PCOS and many other factors 399 
may play a role in PCOS development and progression. Prenatal androgen exposure has been 400 
proposed as a cause of PCOS although the evidence from human studies is inconsistent 401 
(Hickey, et al., 2009). Familial trends in PCOS are reported, but no specific genetic 402 
association has been reported and more research is necessary to define the genetic basis 403 
(Crespo, et al., 2018). Environmental factors, including health-related behaviours or lifestyles 404 
and economic disadvantage, are potentially involved in the aetiology, prevalence, and 405 
modulation of PCOS (Merkin, et al., 2016). It is likely that there are genetic, molecular and 406 
environmental factors that contribute to the racial differences in childhood adiposity-related 407 
PCOS. 408 
The risks of menstrual irregularity and PCOS were significantly higher in women with 409 
persistent overweight/obesity since childhood in both CDAH and BBS, consistent with 410 
findings from the Northern Finland 1966 birth cohort study (Laitinen, et al., 2003). 411 
Furthermore, in our study, for white participants in BBS, we found for the first time that 412 





significantly higher risk of PCOS, suggesting independent effects of childhood adiposity that 414 
need to be confirmed in larger studies.  415 
There are several limitations in our study. First, menstrual cycle characteristics and PCOS 416 
were self-reported by questionnaire. Previous studies have suggested that women’s 417 
retrospective self-report of menstrual length can be prone to error (Small, et al., 2007) and the 418 
agreement between diary records and retrospectively recalled menstrual cycle length was 419 
moderate (Jukic, et al., 2008). Self-reported PCOS likely tends to underestimate prevalence 420 
(Varanasi, et al., 2018; Wang, et al., 2018). Also, if the accuracy of self-reported menstrual 421 
cycle length and PCOS differed by obesity status, then our effect estimates might have been 422 
biased. However, previous studies have shown no evidence of this (Jukic, et al., 2008; 423 
Laitinen, et al., 2003; Small, et al., 2007).  424 
A second potential limitation of this study was the exclusion of women using hormonal 425 
contraception (28.4%) in the analysis of menstrual irregularity in CDAH. Since hormonal 426 
contraception is commonly prescribed for menstrual irregularity (Bulletins—Gynecology, 427 
2013), we may have under-estimated the prevalence of menstrual irregularity. Third, we have 428 
limited information on the age at which PCOS was diagnosed in the two cohorts. Only in the 429 
second follow-up in CDAH were participants asked to report the age when their PCOS was 430 
diagnosed (ages ranged from 14-36 years with only four participants reporting the diagnosis 431 
of PCOS before age 18 years). It has been suggested that adolescents with characteristics of 432 
PCOS should be reassessed at or before full reproductive maturity, at 8 years post menarche 433 
(Teede, et al., 2018) to confirm a diagnosis. In this study, participants reporting a diagnosis of 434 
PCOS during adolescence may have been misclassified. Fourth, the diagnostic criteria for 435 
PCOS have recently changed (Teede, et al., 2018) and there may have been differences in 436 





we showed that the prevalence of menstrual irregularity and PCOS in the two cohorts was 438 
consistent with the literature (March, et al., 2010; Weller and Weller, 1998).  439 
Finally, some characteristics of those continuing in the study differed from those lost to 440 
follow-up, and this might limit the generalizability of the findings. In CDAH, non-441 
participants had higher BMI and WHtR values, on average, in childhood than the 442 
participants, indicating the current sample may have comprised healthier participants. 443 
However, if non-participants were also more likely to have menstrual irregularity and PCOS 444 
in adulthood than participants, the effect of this bias would be to underestimate the magnitude 445 
of the associations observed. Participants in the BBS were more likely to be black (41% 446 
versus 34%) compared with the rest of the study cohort, but childhood BMI was similar 447 
among participants and non-participants (Wang, et al., 2018). 448 
Strengths of our study include that this is the first prospective study to investigate the long-449 
term associations between childhood abdominal obesity measures and menstrual irregularity 450 
and PCOS. Second, we used two independent cohorts from two countries and reported 451 
consistent findings. Third, we were able to consider associations by race in BBS.  452 
In conclusion, greater childhood BMI was associated with an increased risk of menstrual 453 
irregularity in adulthood in both CDAH and BBS. Greater childhood BMI and WHtR were 454 
associated with an increased risk of PCOS in adulthood in CDAH, and in BBS white 455 
participants. These risks were significantly higher in women with persistent 456 
overweight/obesity since childhood. No significant association of adiposity with PCOS was 457 
found in BBS black participants, suggesting there are racial differences in childhood 458 
adiposity associating with the development of PCOS, and other environmental or genetic 459 





indicator of underlying hormonal or metabolic disorders related to PCOS needs further 461 
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Figure legends  634 
Figure 1 Flow chart of the study population for the Childhood Determinants of Adult Health 635 
Study in Australia, 1985–2011. 636 
CDAH: Childhood Determinants of Adult Health 637 
 638 
Figure 2 Flow chart of the study population for the Bogalusa Heart Study in the USA, 1973–639 
2017. 640 
PCOS: polycystic ovary syndrome 641 
